Concord Biotech Limited (CONCORDBIO) — Net Asset Quality Index
Concord Biotech Limited (CONCORDBIO) has a Net Asset Quality Index of 90.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs20.23 Billion minus total liabilities of Rs1.96 Billion yields net assets of Rs18.27 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Concord Biotech Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Concord Biotech Limited Net Asset Quality Index Over Time (2020–2025)
This chart shows how Concord Biotech Limited's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of September 2025, the index stands at 90.3%, representing net assets of Rs18.27 Billion against total assets of Rs20.23 Billion INR. See working capital position of Concord Biotech Limited to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Concord Biotech Limited (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Concord Biotech Limited from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Concord Biotech Limited worth.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.1% | Rs18.13 Billion | Rs20.34 Billion | Rs2.22 Billion | ▼ -0.7 pp |
| 2024 | 89.8% | Rs15.27 Billion | Rs17.01 Billion | Rs1.74 Billion | ▲ +4.6 pp |
| 2023 | 85.2% | Rs12.90 Billion | Rs15.14 Billion | Rs2.24 Billion | ▲ +1.2 pp |
| 2022 | 84.0% | Rs11.03 Billion | Rs13.13 Billion | Rs2.10 Billion | ▼ -0.5 pp |
| 2021 | 84.5% | Rs9.99 Billion | Rs11.83 Billion | Rs1.83 Billion | ▲ +2.6 pp |
| 2020 | 81.9% | Rs7.70 Billion | Rs9.41 Billion | Rs1.70 Billion | — |